Jonathan has a degree in chemistry and doctorate in synthetic
organic chemistry from Oxford University. He is a Fellow of the Royal Society of Chemistry and a Chartered
Scientist. Jonathan is a member of the Board of HGF Limited and is the
head of both the Oppositions & Appeals Team, and the Asia Team at HGF.
Jonathan’s practice involves providing commercially-focused advice
on patent origination, patent strategy and portfolio management, licensing and
due diligence, prosecuting and defending European patent oppositions, and
conducting patent litigation in the UK and Europe.
His practice draws on this variety of
experience and extends to a wide range of chemical and pharmaceutical subject
matter. Jonathan’s practice in the pharmaceutical area has covered both
contentious and non-contentious issues and he has provided external consultancy
services to a number of large pharmaceutical companies over the last 20 years.
His practice involves providing
commercially focused advice to C-suite business leaders, R&D groups, and
public institutions on all aspects of patent strategy and portfolio
management. His practice includes
obtaining and defending patent rights, providing opinions on freedom to operate
where third party intellectual property rights exist, conducting due diligence
to support corporate acquisition and licensing deals, challenging third party
patent rights and pan-European pharmaceutical litigation.
Jonathan has worked on a number of high
profile pharmaceutical matters including working as part of the patent drafting
/ procurement team for Viagra TM; prosecution and litigation
surrounding Augmentin TM, Ritalin TM and Fosrenol TM;
opposition / appeal work on Zithromax TM; and due diligence work to
support the acquisitions of New River Pharmaceuticals and Renovo.
In the non-pharmaceutical area, he has
also been responsible for filing all of the foundation patents for graphene on
behalf of last year’s Nobel Prize winners.
Jonathan’s
clients include large and small companies, universities, and government funded
organisations.
| 
